Retinitis pigmentosa (RP) is a category of hereditary retinal disorders marked by photoreceptor deficiency that progresses through retina degeneration and atrophy. The precise pathogenesis and aetiology of this disorder have remained a mystery until now, and several RP therapies have been tested in animals and in clinical trials. Stem cell transplantation has made some strides in recent years, especially the transplantation of bone marrow-derived mesenchymal stem cells (BMSCs).

Exclusive Coverage gives you access to a comprehensive Retinitis Pigmentosa recovery plan that includes elevated doses of stem cells, cutting-edge stem cell growth factors, intensive therapy, and a variety of complementary treatments and nutrients. Patients have seen major advances thanks to this successful blend of cutting-edge medical technology and practical medicine.

Why Can Stem Cells Help Retinitis Pigmentosa Patients? (RP)

For the management of Retinal Degenerative Disorder, stem cell-based therapy carries a lot of promise.

Many studies have suggested that stem cells such as Umbilical Cord Blood-Derived Stem Cells (UCB-SC), Umbilical Cord Mesenchymal Stem Cells (Ucmsc), and Bone Marrow-Derived Mesenchymal Stem Cells (Bm-Msc) can restore lost photoreceptors and retinal neurons and enhance vision.

Mechanisms are a set of rules that govern how

The following is a potential mode of action for the regeneration of retinal cells.

Neurotrophic factors secreted by stem cells, such as BDNF and GDNF, can promote grafted cell differentiation into neural and retinal ganglion cells, inhibit apoptosis, enhance angiogenesis, suppress inflammatory stimuli, and promote grafted cell survival.

Stem cells help to differentiate cells and have an early reaction to disease, ischemia, and degeneration.

Paracrine effects of Mesenchymal Stem Cells include increased angiogenesis, decreased inflammation, anti-apoptotic and chemotactic signalling, beneficial extracellular matrix remodelling, stimulation of adjacent resident stem cells, and retinal pigment epithelium repair.

Improvements that should be made

Most patients with Retinal Dystrophies and associated retinal disorders who have received novel therapies utilising umbilical cord induced adult stem cells have reported significant enhancements in visual acuity, visual field, light sensitivity, and night vision.

Furthermore, following stem cell therapy, disease development was greatly slowed, resulting in years of vision preservation.

Patients with Retinitis Pigmentosa that receive stem cell treatment typically have changes in the following areas:

• Nystagmus

• Visual acuity

 • Light perception

• Field of view

• Night vision

• Color vision

Our Commitment

We affirm that patients need access to appropriate and secure care and that there is still hope. We are self-contained and have our own medical department. To achieve the highest potential care outcomes, we integrate globally certified hospitals, next-generation therapies, unique products and services that are integrative and reliable.

Stem Cells We can ensure that the patient receives the right and appropriate stem cell form, consistency, quantity, and viability when it comes to stem cells. Our exclusive testing partner guarantees a stem cell viability of 95%, with certain injections reaching a whopping 98-99% viability.

Supportive Therapies & Remedies are a type of therapy that is used to help people who are suffering from We make certain that the patient has the most supportive remedies, treatments, recovery, detoxification, and immune-boosting programmes in order to bring the best out of the stem cells. • Acupuncture • Aquatic Rehabilitation • Physiotherapy Treatment • Occupational Therapy • Transcranial Magnetic Stimulation (rTMS)

• Hemo Oxygen Therapy (HOT)

• IV Vitamin Drips

• Immune-Boosting Supplements (e.g. GcMAF)

• Special Diet Plans & Consultations